Cytotrait (previously Plant Organelle Technologies) focuses on the development of novel traits for food and agriculture.
Cytotrait has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Cytotrait's investors include Northern Universities Venture Fund, Northern Gritstone, ARIA, UK Innovation & Science Seed Fund.
Cytotrait is headquartered in Manchester, United Kingdom.
Cytotrait (previously Plant Organelle Technologies) focuses on the development of novel traits for food and agriculture.
Cytotrait is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytotrait — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/cytotrait. Accessed October 5, 2026.
VCBacked. (2026). Cytotrait — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/cytotrait
{{cite web |title=Cytotrait — Funding & Investors |url=https://www.vcbacked.co/company/cytotrait |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated